{"id":966723,"date":"2026-05-26T08:04:20","date_gmt":"2026-05-26T12:04:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/"},"modified":"2026-05-26T08:04:20","modified_gmt":"2026-05-26T12:04:20","slug":"agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/","title":{"rendered":"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control"},"content":{"rendered":"

<\/p>\n

Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control<\/b><\/p>\n

SANTA CLARA, Calif.–(BUSINESS WIRE<\/a>)–
\nAgilent Technologies Inc. (NYSE: A) today announced the release of a new multi-attribute method (MAM)<\/a> workflow designed to help pharmaceutical and biopharmaceutical quality control (QC) laboratories implement liquid chromatography high-resolution mass spectrometry (LC\/HRMS) in routine, regulated testing environments.<\/p>\n

\nThe Agilent MAM solution brings together software, instrumentation, columns, consumables and standards to address practical and operational barriers that have historically limited the use of LC\/HRMS in QC environments. The workflow is designed to support laboratories applying MAM to monitor critical quality attributes during late-stage development and commercial manufacturing.<\/p>\n

\nRegulatory and industry interest in MAM has increased as biologics grow more complex, and expectations for analytical control continue to evolve. Guidance such as United States Pharmacopeia (USP) chapter <1060> highlights considerations for implementing MAM using LC\/HRMS, reinforcing its relevance for QC lot release and ongoing manufacturing control.<\/p>\n

\n\u201cQuality control laboratories are under increasing pressure to manage more complex biologic products while maintaining consistency, reliability, and compliance,\u201d said Simon May, senior vice president of Agilent\u2019s Life Sciences and Diagnostics Group. \u201cThis workflow reflects Agilent\u2019s focus on helping customers adopt advanced analytical approaches in a way that fits the realities of regulated QC environments.\u201d<\/p>\n

\nThe solution is designed to integrate into existing QC labs using OpenLab CDS, supporting method transfer from research and development into manufacturing. By streamlining data acquisition, analysis, and reporting, the workflow aims to reduce complexity and training requirements while supporting efficient batch release.<\/p>\n

\nIn addition to regulatory drivers, the growing adoption of advanced modalities, including gene therapies, fusion proteins, and antibody-drug conjugates, is increasing demand for analytical techniques capable of monitoring multiple critical quality attributes in a single method. MAM enables consolidation of measurements that have traditionally required multiple, separate tests.<\/p>\n

\n\u201cAs biologic modalities become more complex, laboratories need analytical solutions that help them manage that complexity without disrupting established QC processes,\u201d said Angelica Riemann, senior vice president of the Agilent CrossLab Group. \u201cBy integrating MAM into existing QC workflows, Agilent is helping customers apply advanced analytical approaches where they are needed most, supporting confident, routine use in regulated environments.\u201d<\/p>\n

\nThe Agilent MAM solution is available globally and supports pharmaceutical and biopharmaceutical manufacturers seeking to adopt LC\/HRMS-based methods in regulated QC environments.<\/p>\n

About Agilent Technologies<\/i><\/b><\/p>\n

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent\u2019s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers’ most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at <\/i>www.agilent.com<\/i><\/a>. To receive the latest Agilent news, subscribe to the <\/i>Agilent Newsroom<\/i><\/a>. Follow Agilent on <\/i>LinkedIn<\/i><\/a> and <\/i>Facebook<\/i><\/a>.<\/i><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260526766238\/en\/<\/a><\/span><\/p>\n

Media Contact
\n<\/i><\/b>
Kate Coyle
\n<\/i>
Agilent Technologies Inc.
\n<\/i>
+1 302-633-7490
\n<\/i>
kate.coyle@agilent.com<\/i><\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Software Research General Health Professional Services Hardware Pharmaceutical Data Management Technology Health Technology Data Analytics Science Biotechnology Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) today announced the release of a new multi-attribute method (MAM) workflow designed to help pharmaceutical and biopharmaceutical quality control (QC) laboratories implement liquid chromatography high-resolution mass spectrometry (LC\/HRMS) in routine, regulated testing environments. The Agilent MAM solution brings together software, instrumentation, columns, consumables and standards to address practical and operational barriers that have historically limited the use of LC\/HRMS in QC environments. The workflow is designed to support laboratories applying MAM to monitor critical quality attributes during late-stage development and commercial manufacturing. Regulatory and industry interest in MAM has increased as biologics grow more complex, and expectations for analytical control continue … <\/p>\n

Continue reading “Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-966723","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAgilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) today announced the release of a new multi-attribute method (MAM) workflow designed to help pharmaceutical and biopharmaceutical quality control (QC) laboratories implement liquid chromatography high-resolution mass spectrometry (LC\/HRMS) in routine, regulated testing environments. The Agilent MAM solution brings together software, instrumentation, columns, consumables and standards to address practical and operational barriers that have historically limited the use of LC\/HRMS in QC environments. The workflow is designed to support laboratories applying MAM to monitor critical quality attributes during late-stage development and commercial manufacturing. Regulatory and industry interest in MAM has increased as biologics grow more complex, and expectations for analytical control continue … Continue reading "Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T12:04:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260526766238r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control\",\"datePublished\":\"2026-05-26T12:04:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/\"},\"wordCount\":543,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260526766238r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/\",\"name\":\"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260526766238r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-05-26T12:04:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260526766238r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260526766238r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/","og_locale":"en_US","og_type":"article","og_title":"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control - Market Newsdesk","og_description":"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) today announced the release of a new multi-attribute method (MAM) workflow designed to help pharmaceutical and biopharmaceutical quality control (QC) laboratories implement liquid chromatography high-resolution mass spectrometry (LC\/HRMS) in routine, regulated testing environments. The Agilent MAM solution brings together software, instrumentation, columns, consumables and standards to address practical and operational barriers that have historically limited the use of LC\/HRMS in QC environments. The workflow is designed to support laboratories applying MAM to monitor critical quality attributes during late-stage development and commercial manufacturing. Regulatory and industry interest in MAM has increased as biologics grow more complex, and expectations for analytical control continue … Continue reading \"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-26T12:04:20+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260526766238r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control","datePublished":"2026-05-26T12:04:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/"},"wordCount":543,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260526766238r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/","name":"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260526766238r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-05-26T12:04:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260526766238r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260526766238r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agilent-launches-multi-attribute-method-mam-solution-for-biopharma-quality-control\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/966723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=966723"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/966723\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=966723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=966723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=966723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}